Cancer vaccines: limited success but the research should remain viable

Expert Rev Vaccines. 2016 Jun;15(6):677-80. doi: 10.1586/14760584.2016.1145057. Epub 2016 Feb 9.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Animals
  • Antineoplastic Agents, Immunological / adverse effects
  • Antineoplastic Agents, Immunological / therapeutic use*
  • Biomedical Research / methods*
  • Cancer Vaccines / adverse effects
  • Cancer Vaccines / immunology
  • Cancer Vaccines / therapeutic use*
  • Drug Discovery / methods*
  • Humans
  • Lymphocytes, Tumor-Infiltrating / immunology
  • Neoplasms / immunology
  • Neoplasms / pathology
  • Neoplasms / therapy*
  • Tumor Microenvironment

Substances

  • Antineoplastic Agents, Immunological
  • Cancer Vaccines